Need Help?

Altered Blood and Keratinocyte microRNA/transfer RNA Fragment Profiles Related to Fibromyalgia Syndrome and its Severity

We show dysregulated microRNA and tRNA fragment profiles related to FMS pathopyhsiology and opening new perspectives for FMS diagnostics and symptom monitoring. This dataset includes all sequencing raw files from whole blood (tempus tube) and keratinocyte sequencing.

Request Access

Data access agreement (DAA) for requested access to the dataset Altered Blood and Keratinocyte microRNA/transfer RNA Fragment Profiles Related to Fibromyalgia Syndrome and its Severity

Data access agreement (DAA) for requested access to the dataset Altered Blood and Keratinocyte microRNA/transfer RNA Fragment Profiles Related to Fibromyalgia Syndrome and its Severity DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorized Personnel: The individuals at the User Institution to whom Prof. Dr. med. Nurcan Üçeyler grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorized Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: UKW and the collaborators listed in Appendix I responsible for the development, organization, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorized Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Guidelines for Safeguarding Good Research Practice (Code of Conduct): https://zenodo.org/record/3923602 ( This includes but is not limited to recognizing the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analyzing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify Prof. Dr. med. Nurcan Üçeyler within 30 days of any changes or departures of Authorized Personnel. 13. The User Institution will notify Prof. Dr. med. Nurcan Üçeyler prior to any significant changes to the protocol for the Project. 14. The User Institution will notify Prof. Dr. med. Nurcan Üçeyler as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. Prof. Dr. med. Nurcan Üçeyler may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than UKW. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorized Personnel. The User Institution will procure that the Authorized Personnel comply with the terms of this agreement. Data Recipient or Authorized Representative of the Data Recipient I confirm that I have read and understood this Agreement. Signature: Name: Title: Affiliation: Date: Data Controller(s) or Authorized Representative of the Data Controller(s): Signature: Name: Title: Date: APPENDIX I – DATASET DETAILS APPENDIX II ––PROJECT DETAILS APPENDIX III –– PUBLICATION POLICY APPENDIX I – DATASET DETAILS (to be completed by the data producer before passing to applicant) Dataset reference (EGA Study ID and Dataset Details) Name of project that created the dataset Altered blood and keratinocyte microRNA/transfer RNA fragment profiles related to fibromyalgia syndrome and its severity Names of other data producers/collaborators Dr. Christoph Erbacher, Nimrod Madrer, M.Sc., Prof. Nurcan Üçeyler, Prof. Hermona Soreq File access: Data can be held in unencrypted files on an institutional compute system, with Unix user group read/write access for one or more appropriate groups but not Unix world read/write access behind a secure firewall. Laptops holding these data should have password protected logins and screenlocks (set to lock after 5 min of inactivity). If held on USB keys or other portable hard drives, the data must be encrypted. APPENDIX II – PROJECT DETAILS (to be completed by the Requestor) Details of dataset requested i.e., EGA Study and Dataset Accession Number Brief abstract of the Project in which the Data will be used (500 words max) All Individuals who the User Institution to be named as registered users Name of Registered User Email Job Title Supervisor* All Individuals that should have an account created at the EGA Name of Registered User Email Job Title APPENDIX III – PUBLICATION POLICY UKW intend to publish the results of their analysis of this dataset and do not consider its deposition into public databases to be the equivalent of such publications. UKW anticipate that the dataset could be useful to other qualified researchers for a variety of purposes. However, some areas of work are subject to a publication moratorium. The publication moratorium covers any publications (including oral communications) that describe the use of the dataset. For research papers, submission for publication should not occur until 18 months after these data were first made available on the relevant hosting database. In any publications based on these data, please describe how the data can be accessed, including the name of the hosting database (e.g., The European Genome-phenome Archive at the European Bioinformatics Institute) and its accession numbers (e.g., EGAS00001005004), and acknowledge its use in a form agreed by the User Institution with Prof. Dr. med. Nurcan Üçeyler.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS50000000638 RNASeq

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
EGAF50000209893 fastq.gz 181.0 MB
EGAF50000209894 fastq.gz 236.8 MB
EGAF50000209895 fastq.gz 113.0 MB
EGAF50000209896 fastq.gz 243.1 MB
EGAF50000209897 fastq.gz 278.2 MB
EGAF50000209898 fastq.gz 187.5 MB
EGAF50000209899 fastq.gz 149.5 MB
EGAF50000209900 fastq.gz 233.4 MB
EGAF50000209901 fastq.gz 348.9 MB
EGAF50000209902 fastq.gz 396.1 MB
EGAF50000209903 fastq.gz 265.6 MB
EGAF50000209904 fastq.gz 297.4 MB
EGAF50000209905 fastq.gz 242.2 MB
EGAF50000209906 fastq.gz 166.6 MB
EGAF50000209907 fastq.gz 363.1 MB
EGAF50000209908 fastq.gz 214.0 MB
EGAF50000209909 fastq.gz 346.3 MB
EGAF50000209910 fastq.gz 209.3 MB
EGAF50000209911 fastq.gz 314.3 MB
EGAF50000209912 fastq.gz 337.9 MB
EGAF50000209913 fastq.gz 372.2 MB
EGAF50000209914 fastq.gz 318.8 MB
EGAF50000209915 fastq.gz 200.1 MB
EGAF50000209916 fastq.gz 187.7 MB
EGAF50000209917 fastq.gz 355.2 MB
EGAF50000209918 fastq.gz 269.3 MB
EGAF50000209919 fastq.gz 361.3 MB
EGAF50000209920 fastq.gz 338.2 MB
EGAF50000209921 fastq.gz 255.6 MB
EGAF50000209922 fastq.gz 250.1 MB
EGAF50000209923 fastq.gz 354.3 MB
EGAF50000209924 fastq.gz 331.8 MB
EGAF50000209925 fastq.gz 238.0 MB
EGAF50000209926 fastq.gz 306.7 MB
EGAF50000209927 fastq.gz 365.9 MB
EGAF50000209928 fastq.gz 202.8 MB
EGAF50000209929 fastq.gz 198.5 MB
EGAF50000209930 fastq.gz 236.4 MB
EGAF50000209931 fastq.gz 282.7 MB
EGAF50000209932 fastq.gz 264.0 MB
EGAF50000209933 fastq.gz 277.0 MB
EGAF50000209934 fastq.gz 193.2 MB
EGAF50000209935 fastq.gz 239.7 MB
EGAF50000209936 fastq.gz 252.0 MB
EGAF50000209937 fastq.gz 334.4 MB
EGAF50000209938 fastq.gz 359.4 MB
EGAF50000209939 fastq.gz 327.9 MB
EGAF50000209940 fastq.gz 902.9 MB
EGAF50000209941 fastq.gz 268.7 MB
EGAF50000209942 fastq.gz 273.7 MB
EGAF50000209943 fastq.gz 319.7 MB
EGAF50000209944 fastq.gz 216.0 MB
EGAF50000209945 fastq.gz 373.0 MB
EGAF50000209946 fastq.gz 401.6 MB
EGAF50000209947 fastq.gz 301.8 MB
EGAF50000209948 fastq.gz 225.7 MB
EGAF50000209949 fastq.gz 340.5 MB
EGAF50000209950 fastq.gz 272.7 MB
EGAF50000209951 fastq.gz 124.1 MB
EGAF50000209952 fastq.gz 247.6 MB
EGAF50000209953 fastq.gz 185.2 MB
EGAF50000209954 fastq.gz 208.0 MB
EGAF50000209955 fastq.gz 343.4 MB
EGAF50000209956 fastq.gz 195.2 MB
EGAF50000209957 fastq.gz 208.4 MB
EGAF50000209958 fastq.gz 231.7 MB
EGAF50000209959 fastq.gz 236.9 MB
EGAF50000209960 fastq.gz 220.9 MB
EGAF50000209961 fastq.gz 288.0 MB
EGAF50000209962 fastq.gz 237.8 MB
EGAF50000209963 fastq.gz 304.9 MB
EGAF50000209964 fastq.gz 310.3 MB
EGAF50000209965 fastq.gz 278.0 MB
EGAF50000209966 fastq.gz 257.5 MB
EGAF50000209967 fastq.gz 351.2 MB
EGAF50000209968 fastq.gz 212.6 MB
EGAF50000209969 fastq.gz 266.0 MB
EGAF50000209970 fastq.gz 248.1 MB
EGAF50000209971 fastq.gz 225.4 MB
EGAF50000209972 fastq.gz 234.0 MB
EGAF50000209973 fastq.gz 240.8 MB
EGAF50000209974 fastq.gz 219.7 MB
EGAF50000209975 fastq.gz 205.3 MB
EGAF50000209976 fastq.gz 256.2 MB
EGAF50000209977 fastq.gz 214.2 MB
EGAF50000209978 fastq.gz 239.0 MB
EGAF50000209979 fastq.gz 227.8 MB
EGAF50000209980 fastq.gz 235.2 MB
EGAF50000209981 fastq.gz 296.5 MB
EGAF50000209982 fastq.gz 289.1 MB
EGAF50000209983 fastq.gz 256.2 MB
EGAF50000209984 fastq.gz 249.8 MB
EGAF50000209985 fastq.gz 239.4 MB
EGAF50000209986 fastq.gz 390.1 MB
94 Files (25.7 GB)